首页> Cancer science> An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.

An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.

导出 OA

翻译打印收藏纠错

第一作者： Jean-Pierre,Bikorimana

第一单位： Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Quebec, Canada.

作者： Jean-Pierre,Bikorimana ^[1] ; Jamilah,Abusarah ^[2] ; Marina,Gonçalves ^[3] ; Roudy,Farah ^[1] ; Wael,Saad ^[2] ; Sebastien,Talbot ^[4] ; Daniela,Stanga ^[5] ; Simon,Beaudoin ^[5] ; Sebastien,Plouffe ^[5] ; Moutih,Rafei ^[6]

作者单位： Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Quebec, Canada. ^[1] Department of Pharmacology and Physiology, Université de Montréal, Montréal, Quebec, Canada. ^[2] Department of Molecular Biology, Université de Montréal, Montréal, Quebec, Canada. ^[3] Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada. ^[4] Defence Therapeutics Inc., Vancouver, British Columbia, Canada. ^[5] Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Quebec, Canada.;Department of Pharmacology and Physiology, Université de Montréal, Montréal, Quebec, Canada.;Department of Molecular Biology, Université de Montréal, Montréal, Quebec, Canada. ^[6]

关键词 Accum E7 oncoprotein cervical cancer immune checkpoint inhibitors therapeutic vaccine